Gowlings Logo Life Sciences News @ Gowlings
March 21, 2012

Life Sciences News @ Gowlings image
  Use Twitter?    Follow Gowlings news on Twitter

Biotech firms slam patent decision

Glaxo Joins J&J in $200 Million Fund With Index Ventures

Pharma patent filings fall amid shift to biologics

Paladin Labs' grass allergy drug gets Canadian nod

Novo Nordisk would mull stock split near 1,000 DKK

Panel Backs Glaxo Rare-Cancer Therapy; Rejects Merck Drug

Genomic Test Helps Hundreds of Quebec Women with Early-Stage Breast Cancer Avoid Chemotherapy by Personalizing Their Treatment

3D printer creates working wrench

Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

At any time, you can amend your subscriptions with Gowlings by visiting our website (subscribe | unsubscribe). By your use of this service you agree to the Terms of Use. If you do not agree with the Terms of Use, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.

© 2012 Gowling Lafleur Henderson LLP. All rights reserved.